Protagonist Therapeutics Inc’s (NASDAQ:PTGX) Analysis Might Be Just What You’re Looking For
Protagonist Therapeutics Inc (NASDAQ:PTGX) traded at $45.53 at close of the session on current trade day and made a downward move of -2.00% on its previous day’s price. Looking at the stock we see that its previous close was $46.46 and the beta (5Y monthly)